Navigation Links
Allscripts Reports Third Quarter 2007 Results
Date:11/8/2007

88 million. This target represents annualized growth in total revenue of approximately 25%, and is reflective of approximately 30% annualized growth from software and related services. The Company also updated its GAAP earnings per diluted share outlook to a range of $0.34 to $0.35, representing annualized growth of approximately 55%, and its Non-GAAP adjusted earnings per diluted share outlook to a range of $0.48 to $0.49. Non-GAAP adjusted earnings contemplates the add-back of approximately $6.4 million, or $0.10 per diluted share, of deal-related amortization and approximately $3.0 million, or $0.04 per diluted share, of stock-based compensation, both net of tax.

The Company also provided its outlook for 2008 with annualized growth in total revenue of approximately 20% to 25%, which is reflective of approximately 25% to 30% in annualized growth from software and related services. This target represents annualized growth in GAAP earnings per diluted share of 40% to 50%. Annualized growth in Non-GAAP adjusted earnings per diluted share is expected to be 40% to 45%, which contemplates approximately $6.6 million or $0.10 per diluted share of deal-related amortization, and approximately $6.0 million, or $0.09 per diluted share of stock-based compensation, both net of tax.

Allscripts will conduct a conference call on Thursday, November 8, 2007 at 4:30 PM Eastern Standard Time to discuss the Company's earnings and other information. The conference call can be accessed by dialing 1-888-644-5594 and requesting the Allscripts earnings call, or via the Internet at http://www.allscripts.com. A recording of the conference call will be available for a period of two weeks following the call at http://www.allscripts.com or by calling 1-800-642-1687, ID # 21783504.

Explanation of Non-GAAP Financial Measures

Allscripts reports its financial results in
'/>"/>

SOURCE Allscripts Healthcare Solutions, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
2. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
3. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
4. Allscripts Featured in Microsoft HealthVault Worldwide Launch
5. Lakeside Systems Selects Allscripts Electronic Health Record for 100 Physicians
6. Allscripts to Announce Third Quarter 2007 Results on November 8th
7. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
8. Haemacure Reports Third Quarter 2007 Results
9. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
10. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
11. MDS Reports Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Best-Selling author and P... to discuss Organizational Transformation through ...geles, CA (PRWEB) December 4, 2009 -- IMPAQ Acco...oday that Mark Samuel , best-selling Author, ren...untability Business Consultants Inc., will present...
(Date:12/3/2009)..., , PHILADELPHIA, Dec. 3 /PRNewswire-USNew...ction today against the International Brotherhood ...y blocked vehicles from leaving the facility, inte...,, (Logo: http://www.newscom.com/cgi-bin/prnh/...ted a work stoppage against the American Red Cross...
(Date:12/3/2009)..., , WASHINGTON, Dec. 3 /PRNewswire-USNewsw...rkins responded today to the U.S. Senate,s approv...ikulski (D-MD) to authorize the Health Resources a...ion as "preventive care" in their guidelines. If H... then all group and individual health plans will b...
(Date:12/3/2009)..., , MINNEAPOLIS, Dec. 3 Ch...en named a recipient of the 2009 Leapfrog Top Hosp...zed for delivering care that is among the best in ... of efficiency. ,, The Leapfrog survey is the o...y issues including mortality rates for common proc...
(Date:12/3/2009)..., , CHICAGO, Dec. 3 /PRNewswire-USNewswire...ced today that the United States District Court fo...eliminary approval of the previously disclosed $35...tion lawsuit against UnitedHealth Group. ,, The... State of New York and Missouri State Medical Asso...
Breaking Medicine News(10 mins):Health News:Mark Samuel, CEO & Founder, IMPAQ Accountability Business Consultants Inc., to Present at 14th ICF Annual International Conference 2Health News:American Red Cross Wins Court Injunction Against Striking Teamsters 2Health News:Senate Approval of Mikulski Amendment Further Opens Health Care Bill to Massive Federal Funding of Abortion 2Health News:Children's Hospitals and Clinics of Minnesota Receives National Recognition for Quality and Efficiency 2Health News:Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 2
...ers kick butts, SAN DIEGO, Jan. 21 RealAge.com, ... is launching a new program to guide and,support n...08., RealAge,s new Stop Smoking Center launched t... Young and other,best-selling YOU books. The Cleve...
...s product line and distri... Orthopedics, Inc., an,emerging medical device com... replacement, trauma and tissue regeneration surgi...g will be used,primarily to expand the current pro...
...have a different appearance than other irregular s... a report in the January issue of Archives of Derm...es of malignant melanoma continue to increase, and...ore common in individuals with many moles or other...
...ance on cold medications, study says , , M...special saline nasal wash made from Atlantic seawa...lu, and may prevent recurrence of these infections...-author Dr. Jana Skoupa, of Pharma Projects in Pra...
...ion of,FLAVORx, Inc., which distributes a veterina...y, the nation,s largest compounding pharmacy, have... veterinarians to make pet,medications taste good.... The process is quick, easy and,cost-effective and...
...ge of,Occupational and Environmental Medicine (ACO...ce-based practice guidelines. The chapter on low b...cupational Medicine Practice,Guidelines: Evaluatio... to UMK Professional (Utilization Management Knowl...
Other Medicine News:Health News:RealAge Challenges and Cheers Smoke-Free Wannabes in 2008 2Health News:Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO 2Health News:Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO 3Health News:Melanomas may appear noticeably different than other moles 2Health News:Saline Nasal Wash Helps Kids Fight Colds, Flu 2Health News:Saline Nasal Wash Helps Kids Fight Colds, Flu 3Health News:FLAVORx Teams up with Wedgewood Pharmacy to Make it Even Easier to Make Pet Medications Taste Good 2Health News:FLAVORx Teams up with Wedgewood Pharmacy to Make it Even Easier to Make Pet Medications Taste Good 3Health News:Low Back Disorders Chapter Released 2
(Date:12/3/2009)..., 2009 Raytheon BBN Technologies, ...E: RTN ), has licensed its patented, award-winni...FUJIFILM Corp. ,, FUJIFILM intends to interfac...m. Combined with SDM technology, the Aspire HD dig... for 3-D viewing. FUJIFILM will display the Raythe...
(Date:12/3/2009)...re/ -- Amira Pharmaceuticals, Inc. announced tod...tudy of AM461, the Company,s second oral selective...tor. ,, The interim results demonstrate that ...n be achieved with AM461. Additionally, AM461 Pha...le. AM461 is a back-up to Amira,s lead DP2 antago...
(Date:12/3/2009)...NGALORE, India, December 3 Aditi,T...t and application,development services, today anno...IT Alliance to extend its services focus into Bioi...y evolving industry to leverage Aditi,s,superlativ... and best,practices know-how. , This alli...
Breaking Medicine Technology:Raytheon BBN Technologies Licenses Stereo Digital Mammography Technology to FUJIFILM Corporation 2Raytheon BBN Technologies Licenses Stereo Digital Mammography Technology to FUJIFILM Corporation 3Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amira's Lead DP2 Antagonist, AM211 2Aditi Technologies Join Hands With Microsoft BioIT Alliance to Offer Solutions in Bioinformatics Space 2Signostics Closes Follow On Financing of US 244 Million Expands Board of Directors 13128 1Signostics Closes Follow On Financing of US 244 Million Expands Board of Directors 13128 2Signostics Closes Follow On Financing of US 244 Million Expands Board of Directors 13128 3Go to the doctor 3F Only if Im really sick 52314 1Go to the doctor 3F Only if Im really sick 52314 2Immune System Gene Discovery Sheds Light on Staph Infections 52309 1Immune System Gene Discovery Sheds Light on Staph Infections 52309 2
...mmune today announced,that it has initiated a Phas...asal vaccine in healthy children one month to 12 m...ncytial virus (RSV) infections. RSV is,the most co...e disease in,otherwise healthy infants and childre...n have significant effects,on children. As a leade...
... iSBTc Annual Meeting -, - Conference call to be ..., BRANFORD, Conn., Nov. 3 CuraGen Corporation,(N...om an ongoing Phase II,trial of CR011-vcMMAE, an a... treatment of patients with unresectable Stage III...al Investigator, and Professor and Chairman of,the...
Other Medicine Technology:MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 3CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 4CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 5CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 6CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 7
BluefishRx ICD-9 2005 Coding Tool
Remedy for the Palm
...isease and code numbers in a format for your Palm ...Classification of Diseases, Ninth Revision, Clinic...ealth Organization's Ninth Revision, International...he official system of assigning codes to diagnoses...
WardWatch v3.1.1
Medicine Products: